Skip to main content

Table 1 Comparison of TaqPath and Xpert Xpress Test Results Before Arbitration Testing

From: Comparative evaluation of the Thermo fisher TaqPath™ COVID-19 combo kit with the Cepheid Xpert® Xpress SARS-CoV-2 assay for detecting SARS-CoV-2 in nasopharyngeal specimens

Specimen Total

N = 300

Xpress SARS-CoV-2

(+)

(−)

TaqPathCOVID-19

(+)

58

1

(−)

2

239

Statistic

Value

95% CI

PPA

96.67%

89.13 to 99.76%

NPA

99.58%

96.83 to 99.79%

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us